Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

981
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
981

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Urologic malignancy in renal transplant recipients: Analysis of OPTN/UNOS data from 2000 to 2022.

BMC cancer·2026
Same author

Effect of combined aspirin and statin therapy on mortality reduction in sepsis-induced myocardial injury.

Frontiers in pharmacology·2026
Same author

ISG15 upregulation characterizes a PD-L1-associated immunosuppressive phenotype with CD8<sup>+</sup> T-cell dysfunction in hepatocellular carcinoma.

International immunopharmacology·2026
Same author

The re-emergence of psittacosis in China: a scoping review of epidemiology, diagnostics, and One Health priorities.

Science in One Health·2026
Same author

Symbiont-mediated mechanisms of insecticide resistance in insects.

Journal of insect science (Online)·2026
Same author

A county-level indicator framework for assessing schistosomiasis transmission risk in post-transmission-interruption China.

Infectious diseases of poverty·2026

Related Experiment Video

Updated: Dec 28, 2025

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

710

Monitoring Antiplatelet Aggregation In Vivo and In Vitro by Microtiter Plate Method.

Qiu-Ling Wu1,2, Jun Dong3, Hua-Wu Zeng2

  • 1School of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou, China.

Journal of Cardiovascular Pharmacology
|February 11, 2020
PubMed
Summary
This summary is machine-generated.

This study validates a microtiter plate method for evaluating platelet function, showing it effectively measures antiplatelet aggregation with aspirin and clopidogrel in vitro and in vivo.

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.5K
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.4K

Related Experiment Videos

Last Updated: Dec 28, 2025

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

710
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.5K
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
09:13

Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation

Published on: April 6, 2017

12.4K

Area of Science:

  • Pharmacology
  • Biotechnology
  • Hematology

Background:

  • Traditional light transmission aggregometry for platelet function is time-consuming and lacks parallelism.
  • Existing microtiter plate methods offer high-throughput potential but require further practical validation.

Purpose of the Study:

  • To evaluate the efficacy of a microtiter plate method for assessing platelet aggregation.
  • To validate the method using aspirin and clopidogrel in both in vitro and in vivo settings.

Main Methods:

  • Optimized in vitro assays using varying concentrations of arachidonic acid (AA) and adenosine diphosphate (ADP) agonists with aspirin and clopidogrel.
  • Combination index (CI) calculation to assess synergistic effects of aspirin and clopidogrel.
  • In vivo study in rabbits involving daily administration of aspirin, clopidogrel, or their combination for seven days, followed by platelet aggregation measurement.

Main Results:

  • Established optimal concentrations for AA (50 μM) and ADP (5 μM) to induce concentration-dependent platelet aggregation.
  • Demonstrated concentration-dependent antiplatelet effects of aspirin and clopidogrel in vitro, with synergistic inhibition observed.
  • Confirmed in vivo inhibition of platelet aggregation by aspirin and clopidogrel, with combined therapy showing significantly enhanced effects.

Conclusions:

  • The optimized microtiter plate method, utilizing multiple agonist concentrations, offers a robust approach to platelet function testing.
  • This method mitigates variations in agonist-induced platelet response, presenting a promising tool for platelet aggregation detection.